NCT05782686 is a NA clinical trial of Margin shaving in Margin, Tumor-Free, sponsored by Hospital Universitari de Bellvitge.

Who is sponsoring NCT05782686?

NCT05782686 is sponsored by Hospital Universitari de Bellvitge.

What drugs are being tested in NCT05782686?

Interventions in NCT05782686: Margin shaving.

What condition does NCT05782686 study?

NCT05782686 studies Margin, Tumor-Free, Breast Cancer, Surgery.

Is NCT05782686 still recruiting?

NCT05782686 is currently recruiting now. Last updated 15 September 2025.

Last reviewed 2025-09-15 · How we verify

NCT05782686

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Systematic Shaving on Margins

Recruiting now NA Last updated 15 September 2025

What this trial tests

NA trial testing Margin shaving in Margin, Tumor-Free in 234 participants. Currently enrolling.

Timeline

7 October 2020

Primary endpoint
16 June 2026

16 October 2026

Quick facts

Lead sponsor	Hospital Universitari de Bellvitge
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	234
Start date	7 October 2020
Primary completion	16 June 2026
Estimated completion	16 October 2026
Sites	1 location across Spain

Drugs / interventions tested

Margin shaving

Conditions studied

Margin, Tumor-Free — all drugs for Margin, Tumor-Free →
Breast Cancer — all drugs for Breast Cancer →
Surgery — all drugs for Surgery →

Sponsor

Hospital Universitari de Bellvitge

Who can join

18 and older, female only, with Margin, Tumor-Free or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving technique compared to conventional surgery, and the reduction of second interventions for margin enlargement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital Universitari de Bellvitge trials

Trials by the same sponsor.

NCT07522931 — Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers · recruiting
NCT07155590 — Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia · active not recruiting
NCT06653192 — EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) · NA · recruiting
NCT07178483 — Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure · active not recruiting
NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05782686 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari de Bellvitge
Last refreshed: 15 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05782686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing